These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29097362)

  • 1. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
    Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
    Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
    Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
    J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
    van Vliet HA; Bertina RM; Dahm AE; Rosendaal FR; Rosing J; Sandset PM; Helmerhorst FM
    J Thromb Haemost; 2008 Feb; 6(2):346-51. PubMed ID: 18067603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
    Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
    J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa.
    Plautz WE; Chattopadhyay R; Goldfeld EI; Samelson-Jones BJ; Pilli VS; Campello E; Datta A; Arruda VR; Simioni P; Majumder R
    Thromb Res; 2018 Oct; 170():133-141. PubMed ID: 30189336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
    Tchaikovski SN; Thomassen MCLGD; Stickeler E; Bremme K; Rosing J
    Thromb Res; 2021 Nov; 207():143-149. PubMed ID: 34634502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.
    Tchaikovski SN; Thomassen MC; Costa SD; Peeters LL; Rosing J
    Thromb Haemost; 2011 Nov; 106(5):914-21. PubMed ID: 21979881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.
    Shupp JW; Prior SM; Jo DY; Moffatt LT; Mann KG; Butenas S
    Burns; 2018 Mar; 44(2):436-444. PubMed ID: 29032977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein S: function, regulation, and clinical perspectives.
    Majumder R; Nguyen T
    Curr Opin Hematol; 2021 Sep; 28(5):339-344. PubMed ID: 34224431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.
    Castoldi E; Simioni P; Tormene D; Rosing J; Hackeng TM
    J Thromb Haemost; 2010 Feb; 8(2):294-300. PubMed ID: 20002538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.
    Yang L; Rezaie AR
    J Biol Chem; 2013 May; 288(18):12692-8. PubMed ID: 23530052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives.
    Tchaikovski SN; Thomassen MC; Costa SD; Bremme K; Rosing J
    Thromb Res; 2014 Nov; 134(5):1032-7. PubMed ID: 25260941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives.
    Raps M; Helmerhorst F; Fleischer K; Thomassen S; Rosendaal F; Rosing J; Ballieux B; VAN Vliet H
    J Thromb Haemost; 2012 Jun; 10(6):992-7. PubMed ID: 22469296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
    Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
    J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.